Gentamicin Sulfate Ointment USP, 0.1%

Manufacturer
Teligent Pharma, Inc.
Effective date
2018-04-02
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 20:29:42

Label at a glance#

ProductGentamicin Sulfate
Active ingredientGENTAMICIN SULFATE
Label structure12 sections

Indications and uses

Primary skin infections: Impetigo contagiosa, superficial folliculitis, ecthyma, furunculosis, sycosis barbae, and pyoderma gangrenosum. Secondary skin infections: Infectious eczematoid dermatitis, pustular acne, pustular psoriasis, infected seborrheic dermatitis, infected contact dermatitis (including poison ivy), infected excoriations, and bacterial superinfections of fungal or viral infections. NOTE: Gentamicin...

Dosage and administration

A small amount of Gentamicin Sulfate Ointment USP, 0.1% should be applied gently to lesions three to four times a day. The area treated may be covered with a gauze dressing, if desired. In impetigo contagiosa, the crusts should be removed before application of Gentamicin Sulfate Ointment USP, 0.1% to permit maximum contact between the antibiotic and the infection. Care should be exercised to avoid further contamin...

Storage and handling

Store at 20 to 25˚C (68 to 77˚F) [see USP Controlled Room Temperature].

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx Only

For Dermatologic Use Only

Not for Ophthalmic Use

DESCRIPTION

DESCRIPTION SECTION

Gentamicin Sulfate Ointment USP, 0.1% is a wide spectrum antibiotic preparation for topical administration. Each gram of Gentamicin Sulfate Ointment USP, 0.1% contains Gentamicin Sulfate USP equivalent to 1 mg of gentamicin base in a base of light mineral oil and white petrolatum, with 0.5 mg methylparaben and 0.1 mg propylparaben as preservatives.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Gentamicin Sulfate is a wide spectrum antibiotic that provides highly effective topical treatment in primary and secondary bacterial infections of the skin. This product may clear infections that have not responded to other topical antibiotic agents. In impetigo contagiosa and other primary skin infections, treatment with a small amount of Gentamicin Sulfate Ointment three to four times daily usually clears the lesions promptly. In secondary skin infections, the product facilitates the treatment of the underlying dermatosis by controlling the infection. Bacteria susceptible to the action of Gentamicin Sulfate include sensitive strains of Streptococci (group A beta-hemolytic, alpha-hemolytic), Staphylococcus aureus (coagulase positive, coagulase negative, and some penicillinase-producing strains), and the gram-negative bacteria, Pseudomonas aeruginosa , Aerobacter aerogens , Escherichia coli, Proteus vulgaris and Klebsiella pneumoniae .

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Primary skin infections: Impetigo contagiosa, superficial folliculitis, ecthyma, furunculosis, sycosis barbae, and pyoderma gangrenosum. Secondary skin infections: Infectious eczematoid dermatitis, pustular acne, pustular psoriasis, infected seborrheic dermatitis, infected contact dermatitis (including poison ivy), infected excoriations, and bacterial superinfections of fungal or viral infections. NOTE: Gentamicin Sulfate is a bactericidal agent that is not effective against viruses or fungi in skin infections. It is useful in the treatment of infected skin cysts and certain other skin abscesses when preceded by incision and drainage to permit adequate contact between the antibiotic and the infecting bacteria. Good results have been obtained in the treatment of infected stasis and other skin ulcers, infected superficial burns, paronychia, infected insect bites and stings, infected lacerations and abrasions and wounds from minor surgery. Patients sensitive to neomycin can be treated with Gentamicin Sulfate, although regular observation of patients sensitive to topical antibiotics is advisable when such patients are treated with any topical antibiotic. Gentamicin Sulfate Ointment USP, 0.1% helps retain moisture and has been useful in infection on dry eczematous or psoriatic skin. Gentamicin Sulfate Ointment USP, 0.1% has been used successfully in infants over one year of age as well as in adults and children.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Gentamicin Sulfate Ointment USP, 0.1% is contraindicated in individuals with a history of sensitivity reactions to any of its components.

PRECAUTIONS

PRECAUTIONS SECTION

Use of topical antibiotics occasionally allows overgrowth of nonsusceptible organisms, including fungi. If this occurs, or if irritation, sensitization, or superinfection develops, treatment with Gentamicin Sulfate Ointment USP, 0.1% should be discontinued and appropriate therapy instituted.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

In patients with dermatoses treated with Gentamicin Sulfate, irritation (erythema and pruritus) that did not usually require discontinuance of treatment has been reported in a small percentage of cases. There was no evidence of irritation or sensitization, however, in any of these patients patch-tested subsequently with gentamicin on normal skin. Possible photosensitization has been reported in several patients but could not be elicited in these patients by reapplication of gentamicin followed by exposure to ultraviolet radiation.

To report SUSPECTED ADVERSE REACTIONS, contact Teligent Pharma, Inc. at 1-856-697-1441, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

A small amount of Gentamicin Sulfate Ointment USP, 0.1% should be applied gently to lesions three to four times a day. The area treated may be covered with a gauze dressing, if desired. In impetigo contagiosa, the crusts should be removed before application of Gentamicin Sulfate Ointment USP, 0.1% to permit maximum contact between the antibiotic and the infection. Care should be exercised to avoid further contamination of the infected skin. Infected stasis ulcers have responded well to Gentamicin Sulfate under gelatin packing.

HOW SUPPLIED

HOW SUPPLIED SECTION

Gentamicin Sulfate Ointment USP, 0.1% is available as follows:

15 g tube (NDC 52565-090-15)

30 g tube (NDC 52565-090-30)

STORAGE

STORAGE AND HANDLING SECTION

Store at 20 to 25˚C (68 to 77˚F) [see USP Controlled Room Temperature].

SPL UNCLASSIFIED SECTION

Manufactured By:

Teligent Pharma, Inc.
Buena, NJ 08310

Revised: 04/2018

Principal Display Panel - Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 52565-090-15

Gentamicin Sulfate

Ointment USP, 0.1%*

Net Wt. 15 grams

Rx only

For External Use Only
Not For Ophthalmic Use

15 g carton PDP
15 g carton PDP

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
310465gentamicin sulfate 0.1 % Topical OintmentPSN2
310465gentamicin 0.001 MG/MG Topical OintmentSCD2
310465gentamicin (as gentamicin sulfate) 0.1 % Topical OintmentSY2
310465gentamicin sulfate 0.001 MG/MG Topical OintmentSY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
GENTAMICIN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
3b7b3a7a-635f-32a3-0c6c-7ad028e3de91Product name220250107
43025f0d-698c-68da-cec9-ea4261a7ef7aProduct name220250107
d3946667-8212-d1f2-67e1-5643a329bb56Product name220200403
4ce5dce5-e8a7-e4f6-0059-b527e4307477Product name220190501
48b05f5d-d2fc-45ab-76e8-3cb5bd44890dProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
52565-090-152023-01-30C16284748780-1f386c649-a148-0266-e053-dadaa90a7c1aGentamicin Sulfate Ointment USP, 0.1%
52565-090-302023-01-30C16284748780-1f386c649-a148-0266-e053-dadaa90a7c1aGentamicin Sulfate Ointment USP, 0.1%

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
52565-090-15Gentamicin Sulfate15 g in 1 TUBEOINTMENT152
52565-090-15Gentamicin Sulfate1 in 1 CARTONOINTMENT12
52565-090-30Gentamicin Sulfate1 in 1 CARTONOINTMENT12
52565-090-30Gentamicin Sulfate30 g in 1 TUBEOINTMENT302

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
52565-090GENTAMICIN SULFATE OINTMENT [TELIGENT PHARMA, INC.]2Legacy NDC, 4 package rows20190911_e2fd1885-afad-dcc8-ad64-27d45f63c00f.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
52565-090-15GM - Gram52565-090ec698551-543a-4361-8fc8-860c87e3084912019-04-11
52565-090-30GM - Gram52565-0900ed738bb-f1ca-4fdd-932e-5d3fb269d90812019-04-11

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
52565-09052565-090-15, 52565-090-30

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A209233-001GENTAMICIN SULFATEGENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-31

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-3184e616aacf4f…
2026-08-18 06:07:402026-07A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-31caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-31011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-3131067a03dcf5…
2025-08-23 18:47 UTC2025-08A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-316a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-31fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-31b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-3103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-312680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-315bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-31d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-31d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-3179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-31301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-311e350fbaab3a…
2024-05-31 18:47 UTC2024-05A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-318072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICALAT2018-12-315c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICALAT2018-12-315d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICALAT2018-12-314b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICALAT2018-12-3174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICALAT2018-12-31bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICALAT2018-12-31782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICALAT2018-12-3187673890dc5c…
2021-03-12 10:30 UTC2021-03A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICALAT2018-12-315aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICALAT2018-12-318869cabd3fbd…
2020-11-12 02:37 UTC2020-11A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICALAT2018-12-31c0c555d07b60…
2019-12-14 00:12 UTC2019-12A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICALAT2018-12-313f01610625f2…
2019-09-15 20:21 UTC2019-09A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICALAT2018-12-31b00525d2431f…
2019-07-19 19:46 UTC2019-07A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICALAT2018-12-31ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-316a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-311c564ffb4f44…
2023-12-20 04:57 UTC2023-12A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-31ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-31a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-319b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-31a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICAL2018-12-313f0d92c62455…
2023-05-13 08:27 UTC2023-05A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICALAT2018-12-31053a50430f4f…
2023-01-26 05:58 UTC2023-01A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICALAT2018-12-313bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICALAT2018-12-313a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A209233-001GENTAMICIN SULFATEEQ 0.1% BASEOINTMENT / TOPICALAT2018-12-31f41ea6bd6efb…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A209233-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A209233-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A209233-001AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A209233-001AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A209233-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A209233-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A209233-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03A209233-001AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A209233-001AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A209233-001AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A209233-001AT13f01610625f2…
2019-09-15 20:21 UTC2019-09A209233-001AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07A209233-001AT1ea99ee380514…
2023-05-13 08:27 UTC2023-05A209233-001AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01A209233-001AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A209233-001AT13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A209233-001AT1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A209233-001AT1e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A209233-001AT1cb3db0bc1861…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
bab39bb1-5c1b-498e-889a-18915032086be2fd1885-afad-dcc8-ad64-27d45f63c00f2018-04-02Adverse reactionsExact identifier
spl id: bab39bb1-5c1b-498e-889a-18915032086b
spl set id: e2fd1885-afad-dcc8-ad64-27d45f63c00f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.